• Regenerative Medical Technology Group expanded Cellgenic’s Latin America operations by establishing a regulated commercial platform in Argentina.
• Argentina positioned as a South America hub for biologics distribution through licensed physicians, supported by compliance, training, technical resources.
• Build-out includes expanding the Argentina sales team, scaling distribution into neighboring markets, growing physician education with ISSCA.
• Move supports a broader strategy spanning physician education, biologics commercialization, lab capabilities, international distribution across more than 30 countries.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607230702ACCESSWRNAPR_____1195290) on July 23, 2026, and is solely responsible for the information contained therein.